Allopurinol use and risk of acute coronary syndrome in gout patients: a population-based cohort study in Sweden
Objectives To investigate the impact of allopurinol use on the risk of first-ever acute coronary syndrome (ACS) event in patients with gout.Methods Using national and regional register data, we included all patients with a gout diagnosis at primary or specialised care in Western Sweden in the period...
Saved in:
| Main Authors: | Ulf Lindström, Lennart Jacobsson, Mats Dehlin, Karin Bengtsson, Panagiota Drivelegka, Tatiana Zverkova Sandström |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-02-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/2/e092522.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current issues in the practical use of allopurinol in patients with gout and hyperuricemia
by: M. S. Eliseev
Published: (2024-10-01) -
Comparative risk of retinal microvascular disorders in patients with gout initiating febuxostat versus allopurinol: a population-based cohort study
by: Min Jung Kim, et al.
Published: (2025-08-01) -
Quantum chemical study of anti-gout molecule allopurinol and its dimer by using the first principle
by: Vijay Singh
Published: (2025-07-01) -
Real-life results of urate-driven pharmacotherapy with three urate lowering drugs in gout: allopurinol, febuxostat and benzbromarone
by: Ioana Hotea, et al.
Published: (2023-08-01) -
A systematic review and network meta-analysis of cardiovascular safety of benzbromarone compared to febuxostat and allopurinol in patients with gout
by: Ting-Syuan Lin, et al.
Published: (2025-07-01)